Prognostic value of <scp>PD</scp>‐L1 expression in combination with <scp>CD</scp>8<sup>+</sup><scp>TIL</scp>s density in patients with surgically resected non‐small cell lung cancerHui Yang, Caicun Zhou|Cancer Medicine|2017Cited by 49
Iconographies supplémentaires de l'article : Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyCaicun Zhou, Changxuan You, Gongyan Chen et al.|Unknown|2011Cited by 5